510(k) Report

FDA applicant

Biomedical Diagnostics (Bmd) SA

Marne La Vallee Cedex 2, FR10 decisions2005–20100 recalls

FDA records 10 decisions for Biomedical Diagnostics (Bmd) SA (Marne La Vallee Cedex 2, FR) from 2005 to 2010: 10 510(k) clearances. Most are in product codes MOB (Test System, Antineutrophil Cytoplasmic…) and LLL (Extractable Antinuclear Antibody, Antigen And…). Its devices cite 19 predicates, 4 of them its own earlier devices. No recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, immunology panel, where it files most

How often FDA has decided Biomedical Diagnostics (Bmd) SA’s devices, and how often a recall has named them.

FDA decisions per year

2in 2010

2007: 22010: 2
2007high 2 (2007) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

No recall linked to its devices since 2007.

FIG. 1 — Biomedical Diagnostics (Bmd) SA by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Biomedical Diagnostics (Bmd) SA’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report